fbpx

Diseases and Treatment

Advancing Antimicrobial Development Through AI

During her panel discussion at the World AMR Congress, Akhila Kosaraju, MD, CEO and President of Phare Bio, addressed strategies for modernizing incentive...

An Update on the Pasteur Act

The Pasteur Act has been in Congress for a few years now and seems to be in a holding pattern. This bill authorizes the...

Invasive Sinusitis in a Patient With Febrile Neutropenia and High-Risk Myelodysplastic Syndrome

Final DiagnosisInvasive Fusarium sinusitisHistory of present illnessA 74-year-old White man who initially presented at a local urgent care with a 2-day history of...

Vaxcyte Announces Positive Results For Pneumococcal Vaccine

Vaxcyte is a company developing vaccines to combat bacterial diseases. Its pipeline includes conjugate and protein vaccines for preventing and treating infectious diseases.Image...

New Data on Bemnifosbuvir’s Progress in COVID-19 and HCV Trials

Atea Pharmaceuticals, Inc. announced the publication of additional data on bemnifosbuvir, a drug in development for treating COVID-19 and hepatitis C virus (HCV)....

WHO Enhances Mpox Diagnostics as Emergent BioSolutions’ Vaccine Receives Expanded Approval

Emergent's mission is to protect and enhance life by providing vaccines and therapeutics for urgent public health threats, like the current mpox outbreak,...

Daily Dose of Insights

Get a daily infusion of knowledge with our latest blog updates.

We don’t spam! Read our privacy policy for more info.